{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:12:17Z","timestamp":1778548337730,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jacc.2025.10.035","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:23:11Z","timestamp":1764170591000},"page":"2613-2615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Step by Step to Precision Medicine in Cardiomyopathy Therapy"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0507-2412","authenticated-orcid":false,"given":"Evan P.","family":"Kransdorf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Kittleson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.10.035_bib1","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1038\/s41591-025-03918-x","article-title":"Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial","volume":"31","author":"Marchetti","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2025.10.035_bib2","first-page":"528","article-title":"Progression to stage D heart failure among outpatients with stage c heart failure and reduced ejection fraction","volume":"5","author":"Kalogeropoulos","year":"2017","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2025.10.035_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.122.004028","article-title":"Real-world genetic testing utilization among patients with cardiomyopathy","volume":"17","author":"Morales","year":"2024","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacc.2025.10.035_bib4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jacc.2021.08.039","article-title":"Association of genetic variants with outcomes in patients with nonischemic dilated cardiomyopathy","volume":"78","author":"Escobar-Lopez","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.10.035_bib5","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.jacc.2022.08.804","article-title":"Prognostic prediction of genotype vs phenotype in genetic cardiomyopathies","volume":"80","author":"Paldino","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.jacc.2025.10.035_bib6","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/j.jacc.2025.09.1511","article-title":"Danicamtiv, a selective agonist of cardiac myosin, for dilated cardiomyopathy: a phase 2 open-label trial","volume":"86","author":"Lakdawala","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.10.035_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.10.035_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010134","article-title":"Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease","volume":"7","author":"Roberts","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacc.2025.10.035_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.stemcr.2022.11.008","article-title":"Titin-truncating variants in hiPSC cardiomyocytes induce pathogenic proteinopathy and sarcomere defects with preserved core contractile machinery","volume":"18","author":"Huang","year":"2023","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jacc.2025.10.035_bib10","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/CIRCULATIONAHA.105.567727","article-title":"Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure","volume":"113","author":"Davis","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.10.035_bib11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/CIRCGEN.123.004062","article-title":"Genetic contribution to end-stage cardiomyopathy requiring heart transplantation","volume":"16","author":"Kim","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacc.2025.10.035_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jacc.2021.04.065","article-title":"Effect of ejection fraction on clinical outcomes in patients treated with omecamtiv mecarbil in GALACTIC-HF","volume":"78","author":"Teerlink","year":"2021","journal-title":"J Am Coll Cardiol"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725100041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725100041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:32:49Z","timestamp":1778545969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725100041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":12,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0735109725100041"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.10.035","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Step by Step to Precision Medicine in Cardiomyopathy Therapy","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.09.1511","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}